SINOPHARM GROUP CO. LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.55 HKD | -0.92% |
|
+8.40% | +5.38% |
| 26/04 | Central Bank, Tech Outlooks Lift Major Asian Stock Markets | MT |
| 16/04 | Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets | MT |
ETFs positioned on Sinopharm Group Co. Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.58% | 4 M€ | -27.92% | ||
| 1.36% | 2 M€ | -16.59% | - | |
| 0.48% | 4 M€ | -11.56% | ||
| 0.47% | 2 M€ | -14.14% | ||
| 0.40% | 3 M€ | -0.84% | - | |
| 0.25% | 1 M€ | +3.49% | - | |
| 0.25% | 3 M€ | -.--% | - | |
| 0.06% | 11 M€ | +1.79% | ||
| 0.06% | 441 M€ | +4.60% | - | |
| 0.06% | 2,808 M€ | +5.90% | - | |
| 0.06% | 149 M€ | +2.17% | - | |
| 0.05% | 4 M€ | -4.41% | - | |
| 0.04% | 117 M€ | +1.11% | - | |
| 0.01% | 31 M€ | +3.50% | - | |
| 0.01% | 34 M€ | +6.71% | - | |
| 0.01% | 39 M€ | +3.67% | - | |
| 0.01% | 302 M€ | +3.80% | - | |
| 0.01% | 17 M€ | +1.44% | - | |
| 0.01% | 8 M€ | -0.60% | - | |
| 0.01% | 34 M€ | +2.14% | - | |
| 0.00% | 7 M€ | +1.95% | - | |
| 0.00% | 389 M€ | +6.83% | - | |
| 0.00% | 147 M€ | +4.88% | - | |
| 0.00% | 7 M€ | +0.11% | - | |
| 0.00% | 108 M€ | +2.03% | - |
Sinopharm Group Co Ltd is a China-based company principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is engaged in the operation of chain pharmacy stores. Other Business segment is engaged in the distribution of laboratory supplies, manufacture and distribution of chemical reagents, production and sale of pharmaceutical products.
Sector
Pharmaceuticals
Calendar
13/06/2024
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
19.95
CNY
Average target price
25.06
CNY
Spread / Average Target
+25.63%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +5.38% | 8.59B | |
| +17.35% | 71.39B | |
| +2.39% | 25.1B | |
| +6.69% | 8.19B | |
| -20.96% | 7.91B | |
| +0.49% | 4.54B | |
| +17.12% | 4.31B | |
| -2.61% | 3.86B | |
| +22.08% | 3.64B | |
| +7.96% | 3.29B |
- Stock Market
- Equities
- 1099 Stock
- Funds and ETFs Sinopharm Group Co. Ltd.
